Diabetes Health (press release) Three classes of medications used to treat patients with type 2 diabetes increase insulin levels: sulfonylurea , which increases insulin...
pharmabiz.com A total of 241 people who were ( > /=70 years with T2D, had HbA1c of ( > /=7.0 percent and received metformin and/or sulfonylurea and/or basal insulin were randomized 2:1 to once-daily oral treatment with linagliptin 5 mg or placebo for 24 weeks. In ... and more »
Sacramento Bee A total of 241 people who were (>/=70 years with T2D, had HbA1c of (>/=7.0 percent and received metformin and/or sulfonylurea and/or basal insulin were randomized 2:1 to once-daily oral treatment with linagliptin 5 mg or placebo for 24 weeks. What are ... and more »
Chemistry World Pioglitazone should normally be prescribed as a third-line treatment, after metformin and then either sulfonylurea or gliptin drugs. Pioglitazone is currently available combined with metformin, as well as glimepiride. Formulations containing all three ...
Genetic Engineering News Of these patients, 162 were randomized to receive linagliptin 5 mg and the remaining 79 to receive placebo, in addition to existing glucose-lowering drugs such as metformin and/or sulfonylurea and/or basal insulin. The 24-week study was conducted at a ... and more »
Family Practice News Digital Network He cited as a major impetus for the VA study an eye-opening 2011 report by investigators at the Centers for Disease Control and Prevention that identified insulin and sulfonylurea drugs as the combined number-two cause of emergency hospitalizations for ... and more »
Endocrinology Update it concluded. In Australia, rosiglitazone is currently an Authority Required PBS item, to be prescribed as monotherapy or dual therapy with metformin or a sulfonylurea . Heart, Lung and Circulation 2013; online. Time to revisit rosiglitazone, says ...
Medscape Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with Type 2 diabetes. Diabetes ...
Daily Markets (press release) A total of 241 people who were (>/=70 years with T2D, had HbA1c of (>/=7.0 percent and received metformin and/or sulfonylurea and/or basal insulin were randomized 2:1 to once-daily oral treatment with linagliptin 5 mg or placebo for 24 weeks. What are ... and more »
Medscape ... the likelihood of hypoglycemia, an effect that is heightened among patients receiving concomitant insulin or sulfonylurea treatment, coauthor Wang Jiun-Lin, MD, from I-Shou University and E-Da Hospital, Kaohsiung, Taiwan, told Medscape Medical News. and more »
